Detalhe da pesquisa
1.
Efficacy of Neratinib Plus Capecitabine in the Subgroup of Patients with Central Nervous System Involvement from the NALA Trial.
Oncologist
; 26(8): e1327-e1338, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34028126
2.
Neratinib + capecitabine sustains health-related quality of life in patients with HER2-positive metastatic breast cancer and ≥ 2 prior HER2-directed regimens.
Breast Cancer Res Treat
; 188(2): 449-458, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33909203
3.
Oncology Treatments during the COVID-19 Pandemic in Israel: the ONCOR Study.
Isr Med Assoc J
; 23(12): 759-765, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34954913
4.
First-line ribociclib plus letrozole in postmenopausal women with HR+ , HER2- advanced breast cancer: Tumor response and pain reduction in the phase 3 MONALEESA-2 trial.
Breast Cancer Res Treat
; 169(3): 469-479, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29404806
5.
Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer: interim efficacy results of the randomised, open-label, non-inferiority, phase 3 TURANDOT trial.
Lancet Oncol
; 14(2): 125-33, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23312888
6.
Cannabis is associated with blood pressure reduction in older adults - A 24-hours ambulatory blood pressure monitoring study.
Eur J Intern Med
; 86: 79-85, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33483174
7.
Concomitant expression of the chemokines RANTES and MCP-1 in human breast cancer: a basis for tumor-promoting interactions.
Cytokine
; 44(1): 191-200, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-18790652
8.
Everolimus Plus Letrozole for Treatment of Patients With HR+, HER2- Advanced Breast Cancer Progressing on Endocrine Therapy: An Open-label, Phase II Trial.
Clin Breast Cancer
; 18(2): e197-e203, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29097108
9.
Acupuncture and Reflexology for Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer.
Integr Cancer Ther
; 16(3): 258-262, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28150504
10.
Clinical outcomes in patients with node-negative breast cancer treated based on the recurrence score results: evidence from a large prospectively designed registry.
NPJ Breast Cancer
; 3: 33, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28900633
11.
A biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, temozolomide (Temodal), interferon-alfa and interleukin-2 for metastatic melanoma: a phase II study.
Melanoma Res
; 16(1): 65-9, 2006 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-16432458